
MRTNZ Investment Office · S&P 500 · The 360 Vantage
TMO · NYSE
Thermo Fisher Scientific Inc
Industrials · Industrial Machinery/Components
Reference price$576.41As of Jul 28, 2026
Street view
Analyst targets
Published sell-side aggregation—not an MRTNZ forecast.
Forward calendar
Current earnings expectations
Consensus may change until the company reports.
Dec 2026$25.12Street EPS consensus
Dec 2027$27.46Street EPS consensus
Dec 2028$29.98Street EPS consensus
Reported results
Annual financial snapshot
Fiscal period ended Dec 31, 2025.
MetricCurrentPrior
Revenue+3.9% YoY$44.56B$42.88B
Operating income$7.75B$7.34B
Net income$6.7B$6.34B
Operating cash flow$7.82B$8.67B
Capital expenditures($1.53B)($1.4B)
Current context
Related news
Company-linked articles surfaced by Nasdaq.
Evidence
Sources & method
Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →
Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.